PTAB challenges

Proceedings Overview

As of 2026-05-12, there have been no inter partes review (IPR), post-grant review (PGR), or covered business method (CBM) proceedings filed against U.S. Patent 5,742,768 at the Patent Trial and Appeal Board (PTAB). This absence means the patent has not been challenged at the PTAB, and consequently, none of its claims have been invalidated or sustained through an AIA trial proceeding. For a defendant, this indicates that the patent's validity has not been "hardened" by surviving a PTAB challenge, and all invalidity arguments based on prior art patents and printed publications remain available for a potential future IPR.

(No individual proceedings to list.)

Strategic Summary

The primary takeaway from the PTAB history of U.S. Patent 5,742,768 is the complete lack of any AIA trial proceedings. All claims of the patent—including independent claims 1, 9, and 16—are currently untested at the PTAB. This presents both an opportunity and a challenge for a potential defendant.

On one hand, the estoppel provisions of 35 U.S.C. § 315(e)(2), which prevent a petitioner from later raising invalidity grounds in district court that they "raised or reasonably could have raised" in an IPR, do not apply to any party at this time. A defendant accused of infringing this patent has a full suite of prior art patents and printed publications available to mount a challenge via an IPR petition. There is no risk of a prior petitioner having already made the best arguments, thereby estopping a new defendant from using them.

On the other hand, the absence of prior challenges means there is no record of the patent owner's arguments or the PTAB's claim construction findings to leverage. A defendant would be the first to litigate the patent's validity at the PTAB, which involves the cost and uncertainty of a completely new proceeding. The fact that this patent, issued in 1998 and now owned by a major technology company, has not faced a PTAB challenge is somewhat unusual, especially given the history of litigation noted in its file wrapper. This could suggest that past disputes may have settled before reaching a stage where an IPR was deemed necessary.

Recommended Next Steps

For a defendant currently facing an assertion of U.S. Patent 5,742,768, the path forward is clear from a PTAB perspective:

• Acknowledge the Clean Slate: It must be plainly stated that no PTAB proceedings are on file. The patent is not "IPR-hardened," and no claims have been canceled or substantively amended in response to such a challenge.
• Initiate a Prior Art Search: Since an IPR is a viable defensive option, a comprehensive prior art search focused on patents and printed publications predating the July 16, 1996, priority date should be the immediate first step. The goal is to identify strong grounds for a potential IPR petition based on anticipation (§ 102) or obviousness (§ 103).
• Evaluate IPR as a Defensive Strategy: An IPR offers a faster and often less expensive route to invalidate patent claims compared to district court litigation. Given that no party is estopped, filing a well-supported IPR petition could be a powerful tool to pressure the patent owner into a favorable settlement or to invalidate the asserted claims outright. The lack of a presumption of validity at the PTAB is a significant advantage for a petitioner.